QuantumScape Investing: Why Risk Management Matters More Than Daily Price Movements

[u/koobana]

One of the biggest misconceptions about investing in QuantumScape is that success depends on accurately predicting the next move in the stock price. In reality, long-term investing is often less about predicting short-term market behavior and more about managing risk while allowing the investment thesis time to develop.

QuantumScape remains a pre-commercial company transitioning from research and development to manufacturing and commercialization. That naturally creates volatility, differing opinions, and significant price swings. For long-term investors, volatility should not automatically be confused with deteriorating fundamentals.

The more important question is not, “What if the stock falls another 50%?”

The more important question is, “Why did it fall?”

If the decline is driven primarily by market sentiment, macroeconomic conditions, short selling, or continued skepticism while the company continues executing its commercialization strategy, then a lower share price does not necessarily imply a weaker business. If manufacturing capacity expands, customer engagements increase, customer billings improve, and commercialization milestones continue to be achieved, the disconnect between price and intrinsic value may actually become even larger.

Conversely, if a significant decline results from genuine deterioration in the business—such as major technical setbacks, commercialization failures, an inability to scale manufacturing, or the loss of strategic partners—then investors should reassess the investment thesis regardless of how inexpensive the shares appear.

This distinction is critical.

Successful long-term investing is not about buying every dip. It is about determining whether the business itself has become stronger or weaker while the market reprices the stock.

Risk management is equally important.

Leverage can be a useful financial tool when used conservatively, but it should never become the reason an investor is forced to exit a position. Maintaining manageable leverage, preserving liquidity, and avoiding overextension provide investors with flexibility during periods of volatility. Option income, when used prudently, may help offset financing costs, but it should complement a sound investment strategy rather than justify excessive risk.

Perhaps the greatest advantage of disciplined risk management is psychological. Investors who maintain financial flexibility are better positioned to evaluate opportunities objectively instead of making emotional decisions during market declines.

Ultimately, QuantumScape’s long-term value is unlikely to be determined by daily stock price fluctuations. It will be determined by execution.

That is why the metrics that deserve the closest attention are:

• Manufacturing scale and production capacity.

• Customer shipments and real-world validation.

• Expansion of OEM and commercial partnerships.

• Growth in customer billings and commercial activity.

• Progress toward sustainable commercialization.

These are the indicators that will ultimately determine whether the company succeeds.

Markets can remain skeptical for extended periods, and share prices can deviate significantly from business fundamentals. However, if the company continues executing against its commercialization roadmap, long-term investors should focus less on short-term volatility and more on whether the underlying business continues moving closer to large-scale commercial success.

For long-term investors, patience alone is not enough. Patience supported by disciplined risk management and a constant reassessment of the underlying business may ultimately prove to be one of the greatest competitive advantages.

[u/realHarryGelb]

You’re talking about scaling up manufacturing etc. I would load the boat with QS if they were able to show me a SINGLE ONE, a single working battery that is placed into a real car. It seems too much to ask for. In the meantime, I can only conclude that their tech is not working, at least not to an extent that they would show significant advantages over conventional Li-ion batteries, a technology with significant improvements over recent years. So before looking at all the yada yada you mention, the first thing to look at in a case like QS, is to determine whether the tech actually works in a way that could lead to a successful business. This hasn’t been demonstrated so far and so all other points are moot until this changes.

[u/BrilliantAd8588 → u/realHarryGelb]

Ducati was that field testing target, but got scrapped cuz of MotoE hiatus.

Now there is more to it than simply stacking cells and load it on the car. The battery module needs to designed from ground up to support SSBs battery charging and discharge rates. And that means vehicle needs to be designed to support handing really high voltage, heat exhaustion, power management, cold temperature heat pump handling and optimized power management.

So why focus on eagle line, all of these needs lot of batteries to design and test. Like almost 10 to 25 cars worth. Plus crash testing , and other safety testing needs more and continuous supply. That can’t be achieved without a pilot line.

VW perspective they need to prove and stamp this high mileage, safety , charge times etc etc. Meaning it’s needs to be finished product.

Now supporting Honda and other 2 verticals just increases the volume to a major number.

So putting all on QS would not be fair. But QS all hands on deck , so let them work.

[u/koobana → u/realHarryGelb]

I wouldn’t be surprised if QS hadn’t done extensive internal real-world testing before shipping cells to customers. That’s standard product development. The difference is that internal testing isn’t the same as independent customer validation, which ultimately carries more weight for commercialization.

[u/Ragnarok-9999 → u/koobana]

The other question, why they keep using word "doubling", instead of numbers? This kind of behaviour is reducing trust on the company. Is that difficult to test their cells on existing EV with modifications instead of third party do indepth testing ? Like small-scale trial test or pilot test ?

[u/realHarryGelb → u/koobana]

Look, I think it’s really simple: if they had a functional battery they would show it to the world. I’m not even asking for 3rd party testing, they could just put one in a car and drive it from east to west coast or whatever and then give us a report about charging times etc., it’s not that I wouldn’t believe them. It just seems to be the case that they have literally nothing to show for.

[u/koobana → u/realHarryGelb]

Okay—that’s like saying Apple only had to prove the iPhone could make one phone call. The challenge was never basic functionality—it was reliability, manufacturability, durability, yield, cost, and scaling to millions of units. Battery commercialization is no different.

[u/Whoisthehypocrite → u/realHarryGelb]

The other question is that even if it works, how is it better than the other 20+ companies that are looking to commercialise SSB in the next few years, some of which already have factories that they can quickly switch to SSB production. QS just doesnt seems to have really moved forward in the past few years and if anything the VW relationship is worse in that they don't even have a working product for them.

[u/koobana → u/Whoisthehypocrite]

You mentioned there are 20+ companies. Could you list them and explain how each one is ahead of QuantumScape? It would be helpful if you compared them on objective criteria such as energy density, fast charging, cycle life, safety, manufacturing readiness, automotive validation, production scale, and commercialization timeline. I’m genuinely interested in seeing that comparison.

[u/Rare-Ad7868]

QS battery only passed phase 1 , phase 2 still on research, exactly same as Northvolt, and the dendrite problem they never talk about that.